Volume 9, Number 10—October 2003
Syndromic Surveillance and Bioterrorism-related Epidemics
- Lazarus R, Kleinman KP, Dashevsky I, DeMaria A, Platt R. Using automated medical records for rapid identification of illness syndromes (syndromic surveillance): the example of lower respiratory infection. BMC Public Health. 2001;1:9.
- Mostashari F. BT surveillance in New York City. Presentation at the CDC International Conference on Emerging Infectious Diseases, 2002, Atlanta. [Cited January 2003] Available from: URL: ftp://ftp.cdc.gov/pub/infectious_diseases/iceid/2002/pdf/mostashari.pdf
- Wagner MM, Tsui F, Espino JU, Dato VM, Sittig DF, Caruana RA, The emerging science of very early detection of disease outbreaks. J Public Health Manag Pract. 2001;7:51–9.
- Centers for Disease Control and Prevention. Draft framework for evaluating syndromic surveillance systems for bioterrorism preparedness. [Cited December 2002] Available from: URL: http://www.cdc.gov/epo/dphsi/phs/syndromic.htm
- Committee on Science and Technology for Countering Terrorism, National Research Council of the National Academies. Making the nation safer, the role of science and technology in countering terrorism. Washington: National Academies Press; 2002. p. 74–6.
- Henning KJ. Syndromic surveillance. In: Smolinski MS, Hamburg MA, Lederberg J, editors. Microbial threats to health, emergence, detection, and response. Washington: Institute of Medicine National Academies Press; 2003. Appendix B.
- Lewis MD, Pavlin JA, Mansfield LJ, O’Brien S, Boomsma LG, Elbert Y, Disease outbreak detection system using syndromic data in the greater Washington DC area. Am J Prev Med. 2002;23:180–6.
- Broad WJ, Miller J. Health data monitored for bioterror warning. New York Times, Jan 27, 2003, page A1. [Cited Feb 2003]. Available from: URL: http://www.nytimes.com/2003/01/27/national/27DISE.html
- Centers for Disease Control and Prevention. Press release. CDC provides $1.2 million to fund pilot program for early warning system for terrorism-related illness outbreaks. [Cited Dec 2002] Available from: URL: http://www.cdc.gov/od/oc/media/pressrel/r021002.htm
- Reingold A. If syndromic surveillance is the answer, what is the question? Biosecurity and Bioterrorism. Biodefense Strategy, Practice, and Science. 2003;1:1–5.
- Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis. 2002;8:225–30.
- Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Anthrax as a biological weapon, 2002, updated recommendations for management. JAMA. 2002;287:2236–52.
- Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001;7:933–44.
- Barakat LA, Quentzel HL, Jernigan JA. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA. 2002;287:863–8.
- Bush LM, Abrams BH, Beall A, Johnson CC. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med. 2001;345:1607–10.
- Borio L, Frank D, Mani V, Chiriboga C, Pollman M, Ripple M, Death due to bioterrorism-related inhalational anthrax, report of 2 patients. JAMA. 2001;286:2554–9.
- Mayer TA, Bersoff-Matcha S, Murphy C, Earls J, Harper S, Pauze D, Clinical presentation of inhalational anthrax following bioterrorism exposure, report of 2 surviving patients. JAMA. 2001;286:2549–53.
- Dewan PK, Fry AM, Laserson K, Tierney BC, Quinn CP, Hayslett JA, Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis. 2002;8:1066–72.
- Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis. 2002;8:1019–28.
- Kuehert MJ, Doyle TJ, Hill HA, Bridges CB, Jernigan JA, Dull PM, Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses. Clin Infect Dis. 2003;36:328–36.
- Sartwell PE. The distribution of the incubation periods of disease (historical paper). Am J Epidemiol. 1995;141:386–94.
- Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Tularemia as a biological weapon, medical and public health management. JAMA. 2001;285:2763–73.
- Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, Hemorrhagic fevers viruses as biological weapons: medical and public health management. JAMA. 2002;287:2391–405.
- Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266:1202–7.
- Brookmeyer R, Blades N. Prevention of inhalational anthrax in the US outbreak. Science. 2002;295:1861.
- Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285:1059–70.
- Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Smallpox as a biological weapon: medical and public health management. JAMA. 1999;281:2127–37.
- Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Plague as a biological weapon: medical and public health management. JAMA. 2000;283:2281–90.
- St Louis ME, Peck SH, Bowering D, Morgan GB, Blatherwick J, Banerjee S, Botulism from chopped garlic: delayed recognition of a major outbreak. Ann Intern Med. 1988;108:363–8.
- Meltzer MI, Damon I, LeDuc JW, Millar JD. Modeling potential responses to smallpox as a bioterrorist weapon. Emerg Infect Dis. 2001;7:959–69.
- Gani R, Leach S. Transmission potential of smallpox in contemporary populations. Nature. 2001;414:748–51.
- Kaplan EH, Craft DL, Wein LM. Emergency response to a smallpox attack: the case for mass vaccination. Proc Natl Acad Sci U S A. 2002;99:10935–40.
- Halloran ME, Longini IM, Nizam A, Yang Y. Containing bioterrorist smallpox. Science. 2002;298:1428–32.
- United States Department of Health and Human Services. HHS announces $1.1 billion in funding to states for bioterrorism preparedness. Press release. Jan 31, 2002 [Cited March 2003]. Available from: URL: http://www.hhs.gov/news/press/2002pres/20020131b.html.
- United States Department of Health and Human Services. HHS announces bioterrorism aid for states, including special opportunity for advance fund. Press release. Mar 20, 2003 [Cited March 2003]. Available from: URL: http://www.hhs.gov/news/press/2003pres/20030320.html
- Bresnitz EA, DiFerdinando GT. Lessons from the anthrax attacks of 2001, the New Jersey experience. Clin Occup Environ Med. 2003;2:227–52.
- National Institute of Allergy and Infectious Diseases Office of Communications and Public Liaison. HHS accelerates bioterrorism research: new programs expedite ideas from concerned scientists. Press release. Dec 6, 2001 [Cited March 2003]. Available from: URL: http://www.niaid.nih.gov/newsroom/releases/accelbio.htm
- Smolinski MS, Hamburg MA, Lederberg JA, eds. Microbial threats to health, emergence, detection, and response. Washington: Institute of Medicine National Academies Press; 2003. p. 183–94.
1For interval calculations, if reported event dates were discrepant in different case reports, dates reported by Jernigan et al. (13) were used.
Page created: January 10, 2011
Page updated: January 10, 2011
Page reviewed: January 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.